Boston Children's Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Boston Children's Hospital sits in the top decile of US sponsors by registered trial count (#77 of 15,742 sponsors by registered trial count).
Boston Children's Hospital: 462 sponsored US clinical trials, 110 recruiting.
Boston Children's Hospital sponsors 462 registered US clinical trials on ClinicalTrials.gov, 110 of them currently recruiting, and 268 completed. 35 of these trials are in Phase 3-4 (later-stage) and 53 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Congenital Heart Disease, with 9 trials.
Top-decile sponsor footprint
Boston Children's Hospital ranks in the top decile of sponsors by registered trial count (#77 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
268 of 303 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
462 total, page 10 of 10
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease
NCT00215020
Cutting Balloon Study
NCT01205568
Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy
NCT00323947
Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
NCT00261391
Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Pulmonary Vein Stenosis
NCT00215059
Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis
NCT00215046
A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
NCT00005113
Tissue Bank for Pulmonary Diseases
NCT00546962
Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome
NCT00272844
Cylexin for Reduction of Reperfusion Injury in Infant Heart Surgery
NCT00226369
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
NCT00004404
Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care
NCT00914108
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 30 |
| Phase 2 | 23 |
| Phase 3 | 12 |
| Phase 4 | 23 |
Therapeutic Areas
What is open in the Boston Children's Hospital pipeline
110 recruiting of 462 indexed (24% open); 268 completed (58%).
Phase mix: 35 late (III/IV) vs 53 early (I/II) (early-phase heavy).
Top condition: Congenital Heart Disease (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Boston Children's Hospital: open-pipeline peers nationwide
Peers matched on 462 registered trials and 24% open enrollment, not the therapeutic-area sidebar.
Boston Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 462 trials (± recruiting share)
- University of Virginia · 449 trials · 22% recruiting
- Medical College of Wisconsin · 447 trials · 21% recruiting
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- Fred Hutchinson Cancer Center · 483 trials · 12% recruiting
Sponsors near 24% open enrollment (± trial volume)
- AdventHealth Translational Research Institute · 24% recruiting · 54 trials
- Auburn University · 24% recruiting · 54 trials
- Chugai Pharmaceutical · 24% recruiting · 17 trials
- HALEON · 24% recruiting · 34 trials
Related
What to do with this Boston Children's Hospital page
462 registered trials is a research-attention snapshot, not an endorsement of Boston Children's Hospital or any single study.
- 110 of Boston Children's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Congenital Heart Disease is the condition Boston Children's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Congenital Heart Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Boston Children's Hospital pipeline card: 462 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.